Pathways to breast cancer diagnosis and treatment: exploring the social relations of diagnostic delay. Texto & Contexto - Enfermagem, Florianopolis, v. 16, n. 4, Dec. 2007.ANGUS, J. et al. Pathways to breast cancer diagnosis and treatment: exploring the social relations of diagnostic delay....
an external evaluation of the CISNET Program to assess its past productivity and adherence to its mission in 2018 (offered payment but never received); and serving as an unpaid member of the National Cancer Institute–convened Multi-cancer Early Detection (MCED) Diagnostic Pathways Working Group....
Studies of this question have shed fascinating light into some of the myriad regulatory pathways of p53 function. An early insight into mechanisms of p53 inactivation in breast cancer was afforded by a study of breast cancers of varying p53 mutation status. It was shown that, in a proportion ...
our ability to make clinically useful interventions on the basis of these data is limited. Because of the involvement of multiple genes and complex pathways in a single cancer cell, the molecular dysfunctioning underlying breast cancer remains to be completely clarified. In a next future, studying...
The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. This was a national cohort study of patients with ear
molecular pathways potentially responsible for the development and progression of breast cancer-analyzing the latest therapeutic strategies as well as breakthroughs in endocrine treatments, angiogenesis, and non-hormonal approaches to predict, control, and inhibit the formation and growth of cancerous cells...
over 10 years is estimated to be between 4.8% and 9.4%13. An estimated 13% (1 in 8) of women in the United States will likely be diagnosed with breast cancer in their lifetime, emphasizing the need for access to high-quality diagnosis with implications on optimal treatment pathways10. ...
pathways were still activated in most patients after EGFR-targeted treatment, suggesting that there might be other pathways involved in a bypass activation. As a result, EGFR-targeted treatment alone cannot achieve significant efficacy. Based on the above results and the gene expression profiling ...
Here, we will discuss the relationship between estrogen and breast cancer, the potential role of environmental estrogen mimics on breast cancer progression, and review the current understanding of suspected estrogenic EDCs on altering normal human physiology and estrogen regulated pathways....
(VEGF), could potentially be used as therapeutic approaches to stop the progression of breast cancer due to their roles in various pathways of carcinogenesis, including the cell cycle, angiogenesis, metastasis, etc. [39,40]. These inhibitors have already demonstrated clinical potential. An mTOR-...